DR. CRISTINA G.M. Eng. 3599
The benefits of hormonal therapy in conjunction with radiation treatment as discussed by Dra. Cristina Gutierrez Author: vhsimons Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Can HRT Relieve Migraines in Symptomatic Women?
New research explores the risk/benefit profile of reproductive hormone therapy in menopausal women with migraine. (Source: Medscape Neurology Podcast)
Source: Medscape Neurology Podcast - January 18, 2018 Category: Neurology Authors: Medscape Source Type: podcasts

Hormone Therapy and Chronic Conditions: Let's Get Rational
Hormone therapy must be discussed and individualized for each patient in order to achieve the best outcome for treating menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - January 4, 2018 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Hormonal Therapy in Advanced Endometrial Cancer
This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy. (Source: Medscape Oncology)
Source: Medscape Oncology - December 15, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Levothyroxine and miscarriage, AI detection of breast cancer mets and DM retinopathy, hormone therapy for chronic disease prevention, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 12, 2017 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - December 12, 2017 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

USPSTF Recommendation Statement: Hormone Therapy After Menopause
Interview with Maureen Phipps, MD, Task Force member and co-author of Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 12, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

PodMed – Week of September 18, 2017
This week’s topics include hospital factors relative to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market. Program notes: 0:32 Cost of R and D versus profit in new drugs 1:32 Took 7.3 years 2:35 Reaping in sales far outstrips R and D 3:32 R […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - September 15, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Breast Health Cancer Patient Care PodMed Source Type: podcasts

Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
Interview with JoAnn E. Manson, MD, DrPH, author of Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 12, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

NAMS' Hormone Therapy Statement: Primary Care Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - August 15, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts

NAMS' New Hormone Therapy Position Statement: Clinical Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - August 15, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts

What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - July 17, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts

What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - July 17, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts

How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the'critical window'hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Menopausal Hormone Therapy and Alzheimer Disease Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the'critical window'hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

An Update on Hormonal Therapy for Advanced Prostate Cancer
Are there recent advances in treating advanced prostate cancer patients with hormonal therapy? Listen as a panel of experts, including Dr. Tomasz Beer, Dr. Russell Szmulewitz, Dr. Emmanuel Antonarakis... Author: patientpower Added: 09/08/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 8, 2016 Category: Cancer & Oncology Source Type: podcasts

An Overview of Hormonal Therapy Options for Advanced Prostate Cancer
Expert Dr. Russell Szmulewitz of the University of Chicago Medical Center describes the endocrinology of prostate cancer and provides an overview of hormonal therapies. Dr. Szmulewitz examines the cha... Author: P2Professional Added: 06/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts

An Overview of Hormonal Therapy Options for Advanced Prostate Cancer
Expert Dr. Russell Szmulewitz of the University of Chicago Medical Center describes the endocrinology of prostate cancer and provides an overview of hormonal therapies. Dr. Szmulewitz examines the cha... Author: patientpower Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts

ELITE Provides Reassurance About Estrogen in Early Menopause
The just-published ELITE trial suggests that coronary risk should not be a justification to deny hormone therapy to appropriate candidates in early menopause. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - April 6, 2016 Category: OBGYN Authors: Medscape Source Type: podcasts

ECC 2015: Press programme with updates on post-diagnosis aspirin use, Combi-v, and hormonal therapy in breast cancer
At the European Cancer Congress (ECC) 2015, Peter Naredi, MD, PhD, of the University of Gothenburg, Gothenburg, Sweden, chairs a news briefing with Matteo Lambertini, MD, of IRCCS AOU San Martino-IST,... Author: EMJ Added: 10/08/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 8, 2015 Category: Cancer & Oncology Source Type: podcasts

ECC 2015: Hormonal therapy may prevent ovarian failure and preserve fertility in breast cancer
A meta-analysis was conducted to include 12 randomised trials and a total of 1,231 breast cancer patients receiving chemotherapy, with or without luteinising hormone-releasing hormone analogue (LHRHa)... Author: EMJ Added: 10/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 6, 2015 Category: Cancer & Oncology Source Type: podcasts

Understanding Hormonal Therapy Treatment Options for Advanced Prostate Cancer
Hormonal therapy—or androgen deprivation therapy—has been used for many years to treat men with prostate cancer. How does it work? What are the potential side effects? Drs. Jeri Kim and Sumit K. Subud... Author: patientpower Added: 08/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 19, 2015 Category: Cancer & Oncology Source Type: podcasts

Hormone therapy for preventing cardiovascular disease in post-menopausal women
Whether hormone therapy is, on balance, beneficial or harmful for post-menopausal women has been debated and investigated for some time. In the March 2015 update to the Cochrane Review of the effects on cardiovascular disease, Henry Boardman from the University of Oxford in the UK, and colleagues bring together the findings from 19 randomised trials. He tells us what they found in this Evidence Pod. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - April 15, 2015 Category: Journals (General) Authors: Cochrane Source Type: podcasts

Which Women Are the Best Candidates for HRT?
Dr JoAnn Manson describes how to stratify risk in menopausal women seeking hormone therapy for symptom relief. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - April 10, 2015 Category: Endocrinology Authors: Medscape Source Type: podcasts

Menopausal Hormone Therapy and Risk for Ovarian Cancer
Dr Andrew Kaunitz reviews the results of a new meta-analysis with caution. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - March 24, 2015 Category: Journals (General) Authors: Medscape Source Type: podcasts

Diane Reidy-Lagunes, MD, MS - The Role of Hormonal Therapy in Patients With Neuroendocrine Tumors: Symptom Management and Beyond
The Role of Hormonal Therapy in Patients With Neuroendocrine Tumors: Symptom Management and Beyond (Source: PeerView CME/CE Audio Podcast - Endocrinology)
Source: PeerView CME/CE Audio Podcast - Endocrinology - February 13, 2015 Category: Endocrinology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

ELITE Trial Supports 'Timing Hypothesis' for Estrogen Therapy
Dr JoAnn Manson reviews a recent study that provides further support for the critical window-of-opportunity hypothesis for hormone therapy in atherosclerosis progression. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - January 7, 2015 Category: OBGYN Authors: Medscape Source Type: podcasts

SOFT Yields Hard Data on Hormone Therapy
Drs Kathy Miller and Ann Partridge drill down on the practice-changing data from the SOFT trial, indicating which breast cancer patients should receive ovarian suppression. (Source: Medscape Oncology)
Source: Medscape Oncology - December 22, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Heart Health: Links to Pregnancy and Delivery
Factors that affect a woman's reproductive health can also have an effect on her heart, new research shows. Giving birth prematurely or delivering a small-for-gestational-age baby is associated with a later risk of cardiovascular disease in the mother. Another study found that when women's ovaries were removed and the estrogen was not replaced through hormone therapy, a woman's overall risk of dying increased, as did her risk of dying of heart disease or stroke. (Source: MUSC Heart and Vascular Podcast)
Source: MUSC Heart and Vascular Podcast - December 3, 2014 Category: Cardiology Authors: Medical University of South Carolina Source Type: podcasts

Continuing versus Intermittent Androgen Therapy
When primary therapy in the treatment of prostate cancer fails, hormonal therapy is normally the next step in managing the disease. However much discussion has centered around whether intermittent ... Author: vhsimons Added: 12/01/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 1, 2014 Category: Cancer & Oncology Source Type: podcasts

Best Practices on Long-term Use of Menopausal HT
Dr. Andrew Kaunitz provides guidance on how to answer the common question, 'How long should I continue my hormone therapy?' (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - September 8, 2014 Category: OBGYN Authors: Medscape Source Type: podcasts

Urogenital Atrophy: Vaginal Health for Menopausal Women
Women’s Health Podcast: Urogenital atrophy, also referred to as vaginal dryness is common, affecting as many as 15% of premenopausal women, 10-40% of postmenopausal women, and 10-25% of those taking systemic hormone therapy. Dr. Steven Swift, who specializes in Urogynecology, explains the signs and symptoms of urogenital atrophy and how to treat it with topical or oral estrogen treatments in this women’s health podcast. (Source: MUSC Urology Podcast)
Source: MUSC Urology Podcast - August 12, 2014 Category: Urology & Nephrology Authors: Medical Univeristy of South Carolina Source Type: podcasts

Lessons From WHI, Part 3: Cost-Effectiveness
Drs. Black and Jackson discuss a new cost analysis that demonstrates the value of the WHI hormone therapy study. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - July 8, 2014 Category: Cardiology Authors: Medscape Source Type: podcasts

Lessons From the WHI, Part 1: Hormone Therapy
In part 1 of Dr. Black's interview with Dr. Rebecca Jackson, they review the landmark Women's Health Initiative findings on hormone therapy. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - July 8, 2014 Category: OBGYN Authors: Medscape Source Type: podcasts

Breast Health: Breast Cancer Treatment Hard to Complete for Some
Fewer than half of women with early-stage breast cancer complete their full prescribed course of hormone therapy for breast cancer treatment, says a new study. The South Carolina breast cancer center of MUSC explores this topic in this podcast. (Source: MUSC Women's Health Podcast)
Source: MUSC Women's Health Podcast - April 5, 2014 Category: Primary Care Authors: Medical University of South Carolina Source Type: podcasts

Heart Health: Links to Pregnancy and Delivery
Factors that affect a woman's reproductive health can also have an effect on her heart, new research shows. Giving birth prematurely or delivering a small-for-gestational-age baby is associated with a later risk of cardiovascular disease in the mother. Another study found that when women's ovaries were removed and the estrogen was not replaced through hormone therapy, a woman's overall risk of dying increased, as did her risk of dying of heart disease or stroke. (Source: MUSC Women's Health Podcast)
Source: MUSC Women's Health Podcast - April 5, 2014 Category: Primary Care Authors: Medical University of South Carolina Source Type: podcasts

Breast Health: Breast Cancer Treatment Hard to Complete for Some
Fewer than half of women with early-stage breast cancer complete their full prescribed course of hormone therapy for breast cancer treatment, says a new study. The South Carolina breast cancer center of MUSC explores this topic in this podcast. (Source: MUSC Cancer Podcast)
Source: MUSC Cancer Podcast - April 5, 2014 Category: Cancer & Oncology Authors: Medical University of South Carolina Source Type: podcasts

Heart Health: Links to Pregnancy and Delivery
Factors that affect a woman's reproductive health can also have an effect on her heart, new research shows. Giving birth prematurely or delivering a small-for-gestational-age baby is associated with a later risk of cardiovascular disease in the mother. Another study found that when women's ovaries were removed and the estrogen was not replaced through hormone therapy, a woman's overall risk of dying increased, as did her risk of dying of heart disease or stroke. (Source: MUSC Heart and Vascular Podcast)
Source: MUSC Heart and Vascular Podcast - April 5, 2014 Category: Cardiology Authors: Medical University of South Carolina Source Type: podcasts

News from ASCO GU on the PREVAIL Trial and Enzalutamide
New data suggests a hormonal therapy helps men live longer with advanced prostate cancer. Dr. Chris Parker, a consultant clinical oncologist at The Royal Marsden, explains. Produced in association wi... Author: patientpower Added: 03/24/2014 (Source: Oncology Tube)
Source: Oncology Tube - March 25, 2014 Category: Cancer & Oncology Source Type: podcasts

Take-Home Points From the WHI Hormone Therapy Trials
How should findings from the latest Women's Health Initiative trials inform your clinical decision-making? Dr. JoAnn Manson explains. (Source: Medscape Nurses Podcast)
Source: Medscape Nurses Podcast - October 8, 2013 Category: Nursing Authors: Medscape Source Type: podcasts

13-year outcomes of the WHI hormone therapy trials, opioid use before and after bariatric surgery, bystander CPR and OHCA survival, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 02, 2013 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - October 1, 2013 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials
Interview with JoAnn E. Manson, MD, author of Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - October 1, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

JAMA 2013-10-01, Vol. 310, No. 13, Audio from Weekly Author Video Interview
Interview with JoAnn E. Manson, MD, author of Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - October 1, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Estrogen and the Brain: Do Younger Women Benefit?
Dr. JoAnn Manson discusses whether starting hormone therapy in women ages 50-55 can help them prevent cognitive decline. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - September 19, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

Hormone Therapy: All We Have to Fear Is Fear Itself
Dr. Andrew Kaunitz explains why clinicians and women have been confused regarding the findings of the WHI Hormone Therapy clinical trials. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - August 21, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts